Home » Topics » Regulatory » Patents

Patents
RSS

New E-NPP 2 inhibitors identified at Boehringer Ingelheim

Feb. 16, 2021

Dana-Farber Cancer Institute describes new CDK7/cyclin H inhibitors

Feb. 16, 2021

New dihydroceramide desaturase inhibitors presented by Cincera Therapeutics

Feb. 16, 2021

Sunshine Lake Pharma discovers teixobactin analogues

Feb. 16, 2021

Reata Pharmaceuticals identifies new nitric oxide production inhibitors

Feb. 15, 2021

BioWorld MedTech Patent Highlights: Week 5

From Current Patent Gazette

Feb. 12, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Capella BioScience discovers anti-PD-L1 antibodies

Feb. 12, 2021

Harbin Boyicheng Biotechnology discloses new HER2-targeting nanobodies

Feb. 12, 2021

Bristol Myers Squibb synthesizes IRAK-4 inhibitors

Feb. 12, 2021

Sinocelltech discloses new anti-VEGF antibodies

Feb. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...